Kidney biomarkers in MCPA-induced acute kidney injury in rats: Reduced clearance enhances early biomarker performance

Toxicology Letters

Volumn 225, Issue 3, 2014, Pages 467-478

  Wunnapuk, Klintean ^a,b   Liu, Xin ^a   Gobe, Glenda C ^a   Endre, Zoltan H ^a,c   Peake, Philip W ^c   Grice, Jeffrey E ^a   Roberts, Michael S ^a,d   Buckley, Nicholas A ^e,f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e UNIVERSITY OF PERADENIYA   (Sri Lanka)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

4 Chloro 2 methylphenoxyacetic acid; Acute kidney injury; Biomarkers; Creatinine; Kidney injury molecule 1; MCPA

Indexed keywords

2 (4 CHLORO 2 METHYLPHENOXY)ACETIC ACID; ALBUMINOID; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CREATININE; CYSTATIN C; HAVCR1PROTEIN, RAT; OSTEOPONTIN;

ACUTE KIDNEY FAILURE; ANIMAL; AREA UNDER THE CURVE; BLOOD; CHEMICALLY INDUCED; CYTOCHEMISTRY; MALE; METABOLISM; RAT; RECEIVER OPERATING CHARACTERISTIC; TOXICITY; URINE; WISTAR RAT;

2-METHYL-4-CHLOROPHENOXYACETIC ACID; ACUTE KIDNEY INJURY; ALBUMINS; ANIMALS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CREATININE; CYSTATIN C; HISTOCYTOCHEMISTRY; MALE; OSTEOPONTIN; RATS; RATS, WISTAR; ROC CURVE;

EID: 84893844954     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.01.018     Document Type: Article

References (52)

1. Alter M.L., Kretschmer A., Von W.K., Tsuprykov O., Reichetzeder C., Simon A., Stasch J.P., Hocher B. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin. Lab. 2012, 58:659-671.
2. Aydin H., Ozdemir N., Uzunoren N. Investigation of the accumulation of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat kidneys. Forensic Sci. Int. 2005, 153:53-57.
3. Bellet E.M., van Ravenzwaay B., Pigott G., Leeming N. Chronic dietary toxicity and oncogenicity evaluation of MCPA (4-chloro-2-methylphenoxyacetic acid) in rodents. Regul. Toxicol. Pharmacol. 1999, 30:223-232.
4. Bokenkamp A., Ozden N., Dieterich C., Schumann G., Ehrich J.H., Brodehl J. Cystatin C and creatinine after successful kidney transplantation in children. Clin. Nephrol. 1999, 52:371-376.
5. Bostom A.G., Kronenberg F., Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J. Am. Soc. Nephrol. 2002, 13:2140-2144.
6. Bradberry S.M., Proudfoot A.T., Vale J.A. Poisoning due to chlorophenoxy herbicides. Toxicol. Rev. 2004, 23:65-73.
7. Charlton A.J., Stuckey V., Sykes M.D. Determination of the phenoxyacid herbicides MCPA, mecoprop and 2,4-D in kidney tissue using liquid chromatography with electrospray tandem mass spectrometry. Bull. Environ. Contam. Toxicol. 2009, 82:711-715.
8. de Vries B., Walter S.J., Wolfs T.G., Hochepied T., Rabina J., Heeringa P., Parkkinen J., Libert C., Buurman W.A. Exogenous alpha-1-acid glycoprotein protects against renal ischemia-reperfusion injury by inhibition of inflammation and apoptosis. Transplantation 2004, 78:1116-1124.
9. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
10. Dieterle F., Sistare F., Goodsaid F., Papaluca M., Ozer J.S., Webb C.P., Baer W., Senagore A., Schipper M.J., Vonderscher J., Sultana S., Gerhold D.L., Phillips J.A., Maurer G., Carl K., Laurie D., Harpur E., Sonee M., Ennulat D., Holder D., Andrews-Cleavenger D., Gu Y.Z., Thompson K.L., Goering P.L., Vidal J.M., Abadie E., Maciulaitis R., Jacobson-Kram D., Defelice A.F., Hausner E.A., Blank M., Thompson A., Harlow P., Throckmorton D., Xiao S., Xu N., Taylor W., Vamvakas S., Flamion B., Lima B.S., Kasper P., Pasanen M., Prasad K., Troth S., Bounous D., Robinson-Gravatt D., Betton G., Davis M.A., Akunda J., McDuffie J.E., Suter L., Obert L., Guffroy M., Pinches M., Jayadev S., Blomme E.A., Beushausen S.A., Barlow V.G., Collins N., Waring J., Honor D., Snook S., Lee J., Rossi P., Walker E., Mattes W. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol. 2010, 28:455-462.
11. Elo H.A., Ylitalo P. Distribution of 2-methyl-4-chlorophenoxyacetic acid and 2,4-dichlorophenoxyacetic acid in male rats: evidence for the involvement of the central nervous system in their toxicity. Toxicol. Appl. Pharmacol. 1979, 51:439-446.
12. Endre Z.H., Pickering J.W., Walker R.J. Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am. J. Physiol. Renal Physiol. 2011, 301:F697-F707.
13. EPA Reregistration Eligibility Decision (RED) for MCPA (2-methyl-4-chlorophenoxyacetic acid) List A Case 0017 2004, EPA, Washington, DC.
14. Ferguson M.A., Vaidya V.S., Bonventre J.V. Biomarkers of nephrotoxic acute kidney injury. Toxicology 2008, 245:182-193.
15. Garabrant D.H., Philbert M.A. Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology. Crit. Rev. Toxicol. 2002, 32:233-257.
16. Haase-Fielitz A., Bellomo R., Devarajan P., Story D., Matalanis G., Dragun D., Haase M. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit. Care Med. 2009, 37:553-560.
17. Han W.K., Bonventre J.V. Biologic markers for the early detection of acute kidney injury. Curr. Opin. Crit. Care 2004, 10:476-482.
18. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
19. Hattula M.L., Elo H., Reunanen H., Arstila A.U. Acute and subchronic toxicity of 2-methyl-4-chlorophenoxyacetic acid (MCPA) in male rat I. Light microscopy and tissue concentrations of MCPA. Bull. Environ. Contam. Toxicol. 1977, 18:152-158.
20. Hermida J., Romero R., Tutor J.C. Relationship between serum cystatin C and creatinine in kidney and liver transplant patients. Clin. Chim. Acta 2002, 316:165-170.
21. Hodel C. Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol. Lett. 2002, 128:159-168.
22. Hoffmann D., Fuchs T.C., Henzler T., Matheis K.A., Herget T., Dekant W., Hewitt P., Mally A. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 2010, 277:49-58.
23. Jenkins M.A., Brown D.J., Ierino F.L., Ratnaike S.I. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury. Ann. Clin. Biochem. 2003, 40:364-368.
24. Lappin G.J., Hardwick T.D., Stow R., Pigott G.H., Van Ravenzwaay B. Absorption, metabolism and excretion of 4-chloro-2-methylphenoxyacetic acid (MCPA) in rat and dog. Xenobiotica 2002, 32:153-163.
25. Marrer E., Dieterle F. Impact of biomarker development on drug safety assessment. Toxicol. Appl. Pharmacol. 2010, 243:167-179.
26. OECD OECD Guidelines for the testing of chemicals. Section 4 health effects. Test No 425: Acute Oral Toxicity: Up-and-Down Procedure 2008, 4. OECD: OECD iLibrary, Paris, France.
27. Ortiz A., Sanchez-Nino M.D., Sanz A.B. The meaning of urinary creatinine concentration. Kidney Int. 2011, 79:791.
28. Ozaki K., Mahler J.F., Haseman J.K., Moomaw C.R., Nicolette M.L., Nyska A. Unique renal tubule changes induced in rats and mice by the peroxisome proliferators 2,4-dichlorophenoxyacetic acid (2,4-D) and WY-14643. Toxicol. Pathol. 2001, 29:440-450.
29. Ozer J.S., Dieterle F., Troth S., Perentes E., Cordier A., Verdes P., Staedtler F., Mahl A., Grenet O., Roth D.R., Wahl D., Legay F., Holder D., Erdos Z., Vlasakova K., Jin H., Yu Y., Muniappa N., Forest T., Clouse H.K., Reynolds S., Bailey W.J., Thudium D.T., Topper M.J., Skopek T.R., Sina J.F., Glaab W.E., Vonderscher J., Maurer G., Chibout S.D., Sistare F.D., Gerhold D.L. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat. Biotechnol. 2010, 28:486-494.
30. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of Renal-function-new insights into old concepts. Clin. Chem. 1992, 38:1933-1953.
31. Ralib A.M., Pickering J.W., Shaw G.M., Devarajan P., Edelstein C.L., Bonventre J.V., Endre Z.H. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J. Am. Soc. Nephrol. 2012, 23:322-333.
32. Roberts D.M., Dawson A.H., Senarathna L., Mohamed F., Cheng R., Eaglesham G., Buckley N.A. Toxicokinetics, including saturable protein binding, of 4-chloro-2-methyl phenoxyacetic acid (MCPA) in patients with acute poisoning. Toxicol. Lett. 2011, 201:270-276.
33. Roberts D.M., Seneviratne R., Mohammed F., Patel R., Senarathna L., Hittarage A., Buckley N.A., Dawson A.H., Eddleston M. Intentional self-poisoning with the chlorophenoxy herbicide 4-chloro-2-methylphenoxyacetic acid (MCPA). Ann. Emergency Med. 2005, 46:275-284.
34. Robertson G.L. Antidiuretic hormone. Normal and disordered function. Endocrinol. Metab. Clin. North Am. 2001, 30(vii):671-694.
35. Rouse R.L., Zhang J., Stewart S.R., Rosenzweig B.A., Espandiari P., Sadrieh N.K. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int. 2010, 79:1186-1197.
36. Rowe V.K., Hymas T.A. Summary of toxicological information on 2,4-D and 2,4,5-T type herbicides and an evaluation of the hazards to livestock associated with their use. Am. J. Vet. Res. 1954, 15:622-629.
37. Sadlonova I., Hozova R., Flaskarova E. Adverse effects of herbicide MCPA on dogs in a 90 day toxicological study. Neuro. Endocrinol. Lett. 2006, 2(Suppl 27):108-111.
38. Sohn S.J., Kim S.Y., Kim H.S., Chun Y.J., Han S.Y., Kim S.H., Moon A. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicol. Lett. 2013, 217:235-242.
39. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 2006, 354:2473-2483.
40. Sulik M., Sulik A., Barwijuk-Machala M., Pilat-Marcinkiewicz B. Fetotoxic action of 2,4-dichlorophenoxyacetic acid (2,4-D) III. Morphological changes in rat kidneys. Rocz. Akad. Med. Bialymst. 2002, 47:175-185.
41. Takayasu T., Hayashi T., Ishida Y., Nosaka M., Mizunuma S., Miyashita T., Kawaguchi M., Kimura A., Kondo T. A fatal intoxication from ingestion of 2-methyl-4-chlorophenoxyacetic acid (MCPA). J. Anal. Toxicol. 2008, 32:187-191.
42. Tenstad O., Roald A.B., Grubb A., Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand. J. Clin. Lab. Invest. 1996, 56:409-414.
43. Timchalk C. Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk. Toxicology 2004, 200:1-19.
44. Togel F., Zhang P., Hu Z., Westenfelder C. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J. Cell. Mol. Med. 2009, 13:2109-2114.
45. Uchida K., Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin. Chim. Acta 2002, 323:121-128.
46. Uyanikgil Y., Ates U., Baka M., Bicer S., Oztas E., Ergen G. Immunohistochemical and histopathological evaluation of 2,4-dichlorophenoxyacetic acid-induced changes in rat kidney cortex. Bull. Environ. Contam. Toxicol. 2009, 82:749-755.
47. Vaidya V.S., Ferguson M.A., Bonventre J.V. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 2008, 48:463-493.
48. Vaidya V.S., Waikar S.S., Ferguson M.A., Collings F.B., Sunderland K., Gioules C., Bradwin G., Matsouaka R., Betensky R.A., Curhan G.C., Bonventre J.V. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin. Transl. Sci. 2008, 1:200-208.
49. van Ravenzwaay B., Mellert W., Deckardt K., Kuttler K. The comparative toxicology of 4-chloro-2-methylphenoxyacetic acid and its plant metabolite 4-chloro-2-carboxyphenoxyacetic acid in rats. Regul. Toxicol. Pharmacol. 2005, 42:47-54.
50. van Ravenzwaay B., Pigott G., Leibold E. Absorption, distribution, metabolism and excretion of 4-chloro-2-methylphenoxyacetic acid (MCPA) in rats. Food Chem. Toxicol. 2004, 42:115-125.
51. Waikar S.S., Sabbisetti V.S., Bonventre J.V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int. 2010, 78:486-494.
52. Yasuda M., Maeda H. Teratogenic effects of 4-chloro-2-methylphenoxyacetic acid ethylester (MCPEE) in rats. Toxicol. Appl. Pharmacol. 1972, 23:326-333.